Furthermore, compared to other ABC transporters like ABCC1 and ABCC4, ABCC5 more directly reflects HCC progression and drug resistance, making it highly valuable for precision medicine and targeted therapies in liver cancer. The gene discussed is ABCG2; the disease is hepatocellular carcinoma.